CompletedNot Applicable

Clonal Hematopoiesis of Indeterminate Potential in Venous Thromboembolism

France150 participantsStarted 2020-07-03

Plain-language summary

The aim of the study is to investigate the existence of clonal hematopoiesis of indeterminate potential (CHIP) in patients with a history of venous thromboembolism. The study investigators make the assumption that these patients present mutations involved in CHIP occurrence.

Who can participate

Age range50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women over 50 years old who have consulted at the Hematology laboratory of the Nîmes University Hospital for the occurrence or history of venous thromboembolism * Patient who has accepted that their DNA was kept and used in the context of research on venous thromboembolism (biobank (registration number DC-2008-290 and authorization number AC-2008-107)) Exclusion Criteria: * Patients less than 50 years old * Patient who has refused that their DNA was kept and used in the context of research on venous thromboembolism

What they're measuring

DNMT3A mutations screening

Timeframe: For sequencing analysis: 2 months

Trial details

NCT IDNCT04477564

SponsorCentre Hospitalier Universitaire de Nīmes

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-06-13

View on ClinicalTrials.gov More Venous Thromboembolism trials